Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV. Askari A, Nashier C, Ghelani R, Zhang AV, et al. J Acquir Immune Defic Syndr 2022 Dec 19. doi: 10.1097/QAI.0000000000003151.

Read + Share

Amedeo Smart

Independent Medical Education

Askari A, Nashier C, Ghelani R, Zhang AV, et al. Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV. J Acquir Immune Defic Syndr 2022 Dec 19. doi: 10.1097/QAI.0000000000003151.
PMID: 36729412